Cargando…

Sleep-disordered breathing in patients with cystic fibrosis

OBJECTIVE: To test the hypothesis that disease severity in patients with cystic fibrosis (CF) is correlated with an increased risk of sleep apnea. METHODS: A total of 34 CF patients underwent clinical and functional evaluation, as well as portable polysomnography, spirometry, and determination of IL...

Descripción completa

Detalles Bibliográficos
Autores principales: Veronezi, Jefferson, Carvalho, Ana Paula, Ricachinewsky, Claudio, Hoffmann, Anneliese, Kobayashi, Danielle Yuka, Piltcher, Otavio Bejzman, Silva, Fernando Antonio Abreu e, Martinez, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635955/
https://www.ncbi.nlm.nih.gov/pubmed/26398755
http://dx.doi.org/10.1590/S1806-37132015000004468
Descripción
Sumario:OBJECTIVE: To test the hypothesis that disease severity in patients with cystic fibrosis (CF) is correlated with an increased risk of sleep apnea. METHODS: A total of 34 CF patients underwent clinical and functional evaluation, as well as portable polysomnography, spirometry, and determination of IL-1β levels. RESULTS: Mean apnea-hypopnea index (AHI), SpO(2) on room air, and Epworth Sleepiness Scale score were 4.8 ± 2.6, 95.9 ± 1.9%, and 7.6 ± 3.8 points, respectively. Of the 34 patients, 19 were well-nourished, 6 were at nutritional risk, and 9 were malnourished. In the multivariate model to predict the AHI, the following variables remained significant: nutritional status (β = −0.386; p = 0.014); SpO(2) (β = −0.453; p = 0.005), and the Epworth Sleepiness Scale score (β = 0.429; p = 0.006). The model explained 51% of the variation in the AHI. CONCLUSIONS: The major determinants of sleep apnea were nutritional status, SpO(2), and daytime sleepiness. This knowledge not only provides an opportunity to define the clinical risk of having sleep apnea but also creates an avenue for the treatment and prevention of the disease.